Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Corvus Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −1 vs. Q4 2023
- Shares held
- 17.9M
- −1.28M (−6.7%) vs. Q4 2023
- Total value
- $31.9M
- −$1.90M (−5.6%) vs. Q4 2023
- New holders
- 7
- 11 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,943,654 | $12.4M | 0.24% | 00.0% | Unchanged |
| Adams Street Partners LLC | 3,275,616 | $5.83M | 2.32% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,348,363 | $4.18M | 0.07% | −147,896−5.9% | Reduced |
| Vanguard Group Inc | 1,493,357 | $2.66M | 0.00% | +142,724+10.6% | Added |
| Renaissance Technologies LLC | 637,032 | $1.13M | 0.00% | +49,600+8.4% | Added |
| BlackRock Inc. | 522,978 | $930.9K | 0.00% | +2,427+0.5% | Added |
| Towerview LLC | 382,500 | $680.9K | 0.45% | −54,373−12.4% | Reduced |
| Geode Capital Management, LLC | 371,763 | $661.9K | 0.00% | +11,383+3.2% | Added |
| BVF Inc | 361,406 | $643.3K | 0.02% | −1,009,541−73.6% | Reduced |
| Morgan Stanley | 275,361 | $490.1K | 0.00% | +15,706+6.0% | Added |
| Bridgeway Capital Management, LLC | 224,300 | $399.3K | 0.01% | +75,000+50.2% | Added |
| Two Sigma Advisers, LP | 185,100 | $329.5K | 0.00% | −50,500−21.4% | Reduced |
| State Street Corp | 120,303 | $214.1K | 0.00% | −18,100−13.1% | Reduced |
| Susquehanna International Group, LLP | 105,026 | $186.9K | 0.00% | −115,270−52.3% | Reduced |
| Two Sigma Investments, LP | 102,449 | $182.4K | 0.00% | −78,255−43.3% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 88,008 | $156.7K | 0.00% | +16,800+23.6% | Added |
| Northern Trust Corp | 64,949 | $115.6K | 0.00% | −68−0.1% | Reduced |
| Jackson Square Capital, LLC | 63,773 | $113.5K | 0.03% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 52,824 | $94.0K | 0.00% | +52,145+7,679.7% | Added |
| Hikari Power Ltd | 49,959 | $89.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 23,281 | $41.4K | 0.00% | −17,554−43.0% | Reduced |
| Quinn Opportunity Partners LLC | 22,327 | $39.7K | 0.00% | +22,327 | New |
| Commerce Bank | 20,000 | $35.6K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 18,248 | $32.5K | 0.00% | −214−1.2% | Reduced |
| Resources Investment Advisors, LLC. | 17,950 | $32.0K | 0.00% | +5,550+44.8% | Added |
| Charles Schwab Investment Management Inc | 15,668 | $27.9K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,570 | $22.0K | 0.00% | +12,570 | New |
| Dimensional Fund Advisors LP | 11,924 | $21.2K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,511 | $20.5K | 0.00% | +3,008+35.4% | Added |
| Gillespie Robinson & Grimm Inc | 11,480 | $20.4K | 0.00% | 00.0% | Unchanged |
| Whittier Trust Co of Nevada Inc | 11,200 | $19.8K | 0.00% | 00.0% | Unchanged |
| Fortem Financial Group, LLC | 11,000 | $19.6K | 0.01% | +11,000 | New |
| Masso Torrence Wealth Management Inc. | 10,000 | $17.8K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 9,346 | $16.0K | 0.00% | −40,285−81.2% | Reduced |
| Rothschild Investment LLC | 7,000 | $12.5K | 0.00% | +7,000 | New |
| UBS Group AG | 4,679 | $8.33K | 0.00% | −2,021−30.2% | Reduced |
| Group One Trading, L.P. | 4,604 | $8.20K | 0.00% | −32,060−87.4% | Reduced |
| Northwest Capital Management Inc | 3,397 | $6.05K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2,378 | $4.23K | 0.00% | +2,378 | New |
| Advisor Group Holdings, Inc. | 1,200 | $2.14K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 791 | $1.41K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 265 | $472 | 0.00% | +5+1.9% | Added |
| ICA Group Wealth Management, LLC | 165 | $294 | 0.00% | +165 | New |
| IFP Advisors, Inc | 24 | $43 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $36 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 17 | $30 | 0.00% | +17 | New |
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −71,011−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,415−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,095−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −21,219−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −7,654−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −122−100.0% | Sold out |